|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2027
As of Dec 31, 2026
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash in advance | ||||||||||||||||||||
| Prepaids and other current assets | ||||||||||||||||||||
| Deferred offering costs | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Right-of-use asset, net | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Current maturities of notes payable | ||||||||||||||||||||
| Current maturities of notes payable, net of discounts | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total current maturities of notes payable, net of discounts | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Lease liabilities - current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible notes payable | ||||||||||||||||||||
| Total convertible notes payable | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Notes payable, net of current | ||||||||||||||||||||
| Convertible notes payable, net discounts | ||||||||||||||||||||
| Total convertible notes payable, net discounts | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Mezzanine Equity | ||||||||||||||||||||
| Series B convertible preferred stock, $0.001 par value, 1,500,000 shares authorized; 333,600 shares issued and outstanding as of June 30, 2026 and September 30, 2025 | ||||||||||||||||||||
| Stockholders’ Deficit: | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Series C Convertible Preferred Stock | ||||||||||||||||||||
| Series D Convertible Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Common stock, $0.001 par value, 880,000,000 shares authorized; 163,895,977 and 147,121,825 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders’ Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
Loading...